By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...

No longer confined to cancer centers, skin complications of cancer therapies are now commonly encountered at the community ...

Study Highlights the Efficacy of PMC in Suppressing Non-Small Cell Lung Cancer Growth SEOUL, SOUTH KOREA, January 23, 2026 /EINPresswire.com/ — A South Korean research team has found that ...

The NCCN’s updated guidelines for the treatment of breast cancer include updates on sentinel lymph node biopsy, ovarian ...

Ahead of World Cancer Day on February 4, we look at five community-led organisations addressing the realities of cancer, ...

Zanzalintinib is an investigational oral agent that inhibits tyrosine kinase receptors associated with cancer growth, including TYRO3, VEGF, MET, AXL, and MER.

The government sets aside £10 million a year to help families and young people under 24 access cancer treatment.

Doctors share what the findings may mean for the future of cancer treatment.

Blood Cancer UK, Lymphoma Action and stem cell charity Anthony Nolan have formally appealed against the decision.

After dozens of blood and platelet transfusions, six-year-old Greenleigh Gafford is in remission from leukemia. As blood ...

The University of Florida Health Cancer Institute has once again been recognized as a Cancer Center of Excellence by Gov. Ron ...

Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its ...